Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26242403)

  • 21. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor induction of human papillomavirus type 16 E6/E7 MRNA in tumor cells involves two AP-1 binding sites in the viral enhancer.
    Peto M; Tolle-Ersü I; Kreysch HG; Klock G
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1945-58. PubMed ID: 7636475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
    Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
    Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y
    Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies.
    Kozuka T; Aoki Y; Nakagawa K; Ohtomo K; Yoshikawa H; Matsumoto K; Yoshiike K; Kanda T
    Jpn J Cancer Res; 2000 Mar; 91(3):271-9. PubMed ID: 10760685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells.
    Wang H; Gao P; Zheng J
    Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7.
    Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC
    Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
    Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
    Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
    Liu WL; Green N; Seymour LW; Stevenson M
    Cancer Gene Ther; 2009 Oct; 16(10):764-75. PubMed ID: 19363466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53.
    Au Yeung CL; Tsang WP; Tsang TY; Co NN; Yau PL; Kwok TT
    Oncol Rep; 2010 Dec; 24(6):1599-604. PubMed ID: 21042757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
    Diaz D; Santander MA; Chavez JA
    Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.
    de la Cruz-Hernández E; Pérez-Cárdenas E; Contreras-Paredes A; Cantú D; Mohar A; Lizano M; Dueñas-González A
    Virol J; 2007 Feb; 4():18. PubMed ID: 17324262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus type 16 E7 oncoprotein mediates CCNA1 promoter methylation.
    Chalertpet K; Pakdeechaidan W; Patel V; Mutirangura A; Yanatatsaneejit P
    Cancer Sci; 2015 Oct; 106(10):1333-40. PubMed ID: 26250467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
    Munagala R; Kausar H; Munjal C; Gupta RC
    Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional regulation of genes involved in keratinocyte differentiation by human papillomavirus 16 oncoproteins.
    Gyöngyösi E; Szalmás A; Ferenczi A; Póliska S; Kónya J; Veress G
    Arch Virol; 2015 Feb; 160(2):389-98. PubMed ID: 25488293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cell-based high-throughput assay for screening inhibitors of human papillomavirus-16 long control region activity.
    Lembo D; Donalisio M; De Andrea M; Cornaglia M; Scutera S; Musso T; Landolfo S
    FASEB J; 2006 Jan; 20(1):148-50. PubMed ID: 16254045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.